The loss of miR-146a-5p may enhance epithelial-mesenchymal transition (EMT), thereby accelerating the metastasis of cancer cells by regulating the epidermal growth factor receptor (EGFR)/ERK pathway 99. The gene discussed is EGFR; the disease is cancer.